GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes

Published date 2011-11-16 15:13
Head-to-head study primary end point did not meet non-inferiority, but results support progression towards registration

Skriv et svar

Din e-mailadresse vil ikke blive publiceret. Krævede felter er markeret med *